| Literature DB >> 19754974 |
Xiaohu Shao1, Mengtian Jiang, Ziniu Yu, Hao Cai, Lin Li.
Abstract
BACKGROUND: Previous studies have revealed that the lysin motif (LysM) domains of bacterial cell wall-degrading enzymes are able to bind to peptidoglycan moieties of the cell wall. This suggests an approach for a cell surface display system in Gram-positive bacteria using a LysM-containing protein as the anchoring motif. In this study, we developed a new surface display system in B. thuringiensis using a LysM-containing peptidoglycan hydrolase, endo-beta-N-acetylglucosaminidase (Mbg), as the anchor protein.Entities:
Year: 2009 PMID: 19754974 PMCID: PMC2754439 DOI: 10.1186/1475-2859-8-48
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Figure 1Schematic representation of the Mbg protein. (A) General organization of Mbg. AA, amino acid residues; LysM, lysin motif. (B) The putative secondary structure of the N-terminal domain of Mbg.
Figure 2Flow cytometry analysis of . Cells were labelled with primary monoclonal anti-GFP antibody, followed by secondary Cy5-conjugated goat anti-mouse IgG. The histogram on the top right corner of each figure shows total GFP/Cy5-labelled fluorescent cells, and the values indicate their percentages of total cell counts. For each detection, a total of 100,000 cells were analyzed.
Figure 3Expression profiles of . (A) Time course of (a) cell growth and (b) specific GFP fluorescence intensity of MB162 cells expressing Mbg-GFP fusion protein. Cells were cultured in LB at 30°C in the presence of 25 μg/mL of erythromycin, then harvested and diluted to unit cell density (OD600 = 1) with PBS buffer (pH7.0) for GFP fluorescence intensity determination. (B) SDS sensitivity and pronase accessibility assays of MB162 intact cells and the control cells expressing only cellular GFP. Relative values were based on GFP fluorescence intensity at the initial incubation time. Each value and error bar represents the mean of three independent experiments and its standard deviation. The values of MB162 cells without pronase or SDS treatment remained unvaried during the time course (data not shown). (C) Western blot analysis of MB162 cell fractions. Lane 1, cell-wall fraction; lane 2, soluble cytoplasmic fraction; lane 3, whole cell lysate; lane 4, BMB171 (the negative control). (D) GFP specific fluorescence intensity measurement of cell-wall (CW) and cell cytosol fractions.
Figure 4Flow cytometric analysis of . Cells were labelled with primary monoclonal anti-GFP antibody, followed by secondary Cy5-conjugated goat anti-mouse IgG. The value of each histogram indicates the percentage of total GFP/Cy5-labelled fluorescent cells. For each experiment, 100,000 cells were analyzed.
Figure 5Microscopic observation of . For immunofluorescence microscopy (A), cells were treated with anti-GFP monoclonal antibody and followed with goat anti-mouse Cy3-conjugate antibody. Panels show the images observed by phase contrast microscopy and fluorescence microscopy using green and red emission filters. For immunochemical electron microscopy (B), the samples were further treated with 10 nm colloidal gold-conjugated goat anti-mouse IgG. Arrows indicate the gold particles. The scale bars represent 500 nm.
Figure 6Cell-wall binding efficiency analysis of recombinant . (A) Western blot analysis of cell-wall fractions. All fractionated samples were prepared in parallel, and an equal volume of each sample was used for analysis. The relative amount of fusion protein shown on each lane was quantified using the amount of (Mbgn)2-GFP as the reference value (100%). Abbreviations: Mbgn, the N-terminal domain of Mbg; Mbgc, the C-terminal domain of Mbg; lysM, the lysin motif; GFP, green fluorescence protein; (Mbgn)2, two tandemly aligned Mbgn repeats; (Mbgn)3, three tandemly aligned Mbgn repeats. (B) Total GFP fluorescence intensities of BMB171 and the recombinant B. thuringiensis cells expressing GFP-fusion proteins with various anchoring domains. (C) Flow cytometric analysis of BMB171 and the recombinant B. thuringiensis cells expressing GFP-fusion proteins with various anchoring domains. (a) BMB171; (b) MB163 cells expressing Mbg-GFP; (c) MB164 cells expressing Mbgn-GFP; (d) MB166 cells expressing LysM1-GFP; (e) MB168 cells expressing (Mbgn)2-GFP; and (f) MB169 cells expressing (Mbgn)3-GFP. The value of each histogram indicates the percentage of total Cy5-labelled fluorescent cells. For each experiment, 100,000 cells were analyzed.
Figure 7Schematic illustration of the recombination plasmids harbouring different anchoring domains. The resulting recombination plasmids are designated on the right array, while the middle array shows the gene maps of various domains or repeats of mbg that are driven by the promoter P. The region comprising cell wall binding domain LysM1 is highlighted. The boxes representing different domains are not shown to scale. Abbreviations: P, the promoter of cry3Aa; mbgn, the N-terminal domain of mbg; mbgc, the C-terminal domain of mbg; lysM, the lysin motif encoding domain; gfp, green fluorescence protein encoding gene.
Figure 8Verification of surface display of WlacD in recombinant . (A) Western blot analysis of cell fractions prepared from MB174 cells expressing (Mbgn)2-wlacD and MB173 cells expressing cellular wlacD. WC, whole cell fractions; CW, cell-wall fractions; CC, cell cytoplasmic fraction. (B) Microscopic observation of MB173 and MB174 intact cells that were treated with anti-WlacD polyclonal antibody and followed with goat anti-mouse Cy3-conjugate antibody. (C) Measurement of whole-cell laccase activity using ABTS as the substrate. Each value and error bar represents the mean of three independent experiments and its standard deviation.
Plasmids and oligonucleotide primers used in this study
| Plasmids | ||
| pHT304 | AmprEmr, | [ |
| pGFPuv | Ampr, plasmid vector carrying a variant of | CLONTECH Lab, Inc. |
| pBMB3305 | AmprEmr, pHT304 derivative harbouring insecticidal gene | Laboratory collection |
| pMB172 | Ampr, pTYB12 derivative harbouring | [ |
| pMB160 | AmprEmr, pHT304 derivative harbouring | This study |
| pMB161 | AmprEmr, pHT304 derivative harbouring | This study |
| pMB162 | AmprEmr, pHT304 derivative harbouring | This study |
| pMB163 | AmprEmr, pHT304 derivative harbouring promoter | This study |
| pMB164 | AmprEmr, pHT304 derivative harbouring | This study |
| pMB165 | AmprErmr, pHT304 derivative harbouring | This study |
| pMB166 | AmprEmr, pHT304 derivative harbouring | This study |
| pMB167 | AmprEmr, pHT304 derivative harbouring | This study |
| pMB168 | AmprEmr, pHT304 derivative harbouring | This study |
| pMB169 | AmprEmr, pHT304 derivative harbouring | This study |
| pMB173 | AmprEmr, pHT304 derivative harbouring | This study |
| pMB174 | AmprEmr, pHT304 derivative harbouring | This study |
| Oligonucleotide primersb | ||
| BT101 | 5'-CGA | |
| BT102 | 5'-TTCTTCTCCTTTACTCATACAGAAAATATGTTTACCG-3' | |
| BT103 | 5'-CGGTAAACATATTTTCTGTATGAGTAAAGGAGAAGAA-3' | |
| BT301 | 5'-CGT | |
| BT302 | 5'-TTCTTCTCCTTTACTCATCCTAACTAAATATGGCAG-3' | |
| BT303 | 5'-CTGCCATATTTAGTTAGGATGAGTAAAGGAGAAGAA-3' | |
| P1 | 5'-TTA | |
| P2 | 5'-TTCTTCTCCTTTACTCATGCCCTTTTTCGTAATCGT-3' | |
| P3 | 5'-ACGATTACGAAAAAGGGCATGAGTAAAGGAGAAGAA-3' | |
| P4 | 5'-AAA | |
| P5 | 5'-ACGG | |
| P6 | 5'-CTG | |
| P7 | 5'-CCAAGT | |
| P8 | 5'-GCT | |
| P9 | 5'-ACGA | |
| P10 | 5'-TCTAG | |
| P11 | 5'-CTG | |
| P12 | 5'-GCA | |
| P13 | 5'-CGC | |
| P14 | 5'-CGC | |
| P15 | 5'-CTG | |
| P16 | 5'-AAA | |
| P17 | 5'-GCA |
a Emr, erythromycin resistance; Ampr, ampicillin resistance; cry3Aa, B. thuringiensis insecticidal gene;P, the promoter of cry3Aa; gfp, green fluorescent protein gene; wlacD, a mutated S. dysenteriae laccase gene [20]; mbg, a putative N-acetylglucosaminidase gene from B. thuringiensis YBT-1520; mbgn, N-terminal domain of mbg; mbgc, C-terminal domain of mbg; (mbgn)2, two tandemly aligned repeats of N-terminal domain of mbg.
b The underlined sequences indicates the restriction enzyme sites.